Skip to main content
Premium Trial:

Request an Annual Quote

NCICB Seeks Comment, Geospiza, Oracle Life Sciences Users Group Meeting, NCI, FDA Host Biomarker Workshop

Premium

NCICB Seeks Comment on Data Standards Draft

The National Cancer Institute Center for Bioinformatics has released for public comment a draft document covering data content standards for clinical and basic science.

NCICB said it commissioned SAIC to review current data content standards in order to prepare the draft, which is available for a two-week public comment period at ftp://ftp1.nci.nih.gov/pub/cacore/ExternalStds/.

NCICB said it plans to incorporate comments and to release a final version of the document by the end of June.


Geospiza Partners with AME, Biomax

Geospiza last week announced reseller partnerships with AME Bioscience and Biomax Solutions.

In the AME deal, Geospiza’s Finch Sequencing Center software system will be bundled with refurbished or pre-owned sequencing instruments from Applied Biosystems and Amersham Bioscience (Now GE Healthcare).

Under the Biomax agreement, the firms will integrate sell their software together in a package called the Optimized Research Environment.


Oracle Holds Life Science User Group Meeting

Oracle will be hosting its fourth Oracle Life Sciences Users Group Meeting, June 23-24 in Reston, Va.

A full agenda and registration information are available at http://otn.oracle.com/industries/life_sciences/olsug/olsug_june2004.html.


NCI, FDA Host Biomarker Validation Workshop

The National Cancer Institute and the Food and Drug Administration will host a workshop in Bethesda, Md., on July 28-29 called, “Research Strategies, Study Designs and Statistical Approaches to Biomarkers Validation for Cancer Diagnosis and Detection.”

The workshop will address study design, statistical methodologies, and validation approaches to cancer biomarkers, and consider approaches to their validation for clinical utility.

A major goal of the workshop, according to the organizers, is “to develop a position paper on state-of-the-art in biomarker validation study.”

Additional information is available at http://www.scgcorp.com/biomarkers2004/.

Filed under

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.